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LET’IYERS TO THE EDlTOR 
Effect of Smoking Status on Response to 
Thrombolytic Therapy 
Barbash et al. (1) analyzed the relation between smoking status and 
outcome after thrombolytic therapy for acute myocardial infarction in 
the GUSTO-1 trial. The authors concluded that the superior sunrival 
of smokers is mostly accounted fo by their younger age. However, in 
their analysis of the entire cohort, smoking remained an independent 
prediior of survival after age had been accounted for, which is in 
agreement with similar observations by the same authors using the 
international study data (2). It was only in their analysis of the 
angiogmphic substudy of GUSTO that smoking status was no ionger 
predictive of suwival after correction for age and gender. However. 
this may have resulted from inadequate correction for Thrombolysis in 
Mywcardial infarction (TIMI) flow grade. 
We recently reported data from the TIMI- trial (3) showing that 
smokers more frequently have TIM1 grade 3 flow in their infarct- 
related arteries 98 min after initiation of thtombolysis. This observa- 
tion, previously reported by Gomez et al. (4) and now contirmed in the 
larger GUSTO data base, may explain in part the superior outcome of 
smokers after thmmbolysis. Because improved early reperfiuion may 
be a mechanism linking smoking and improved sun&d, it may be 
inapproprhte to correct the observed mortality for the TfMf flow 
grade. We believe that younger age, as well as a better response to 
thmmbolytic therapy, explain the superior outcome of smokers in 
acute myocardial infarction. 
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We appreciate the comments made by Zahger and Shah regarding the 1. How often and under what circumstanoes did scan results influence 
e&d of smoking status in response to thrombofyttc therapy. the decision to perform coronary angioppby? 
Smokers have numerous favorable ciinical as well as angLographic 2. Given the novelty of electron beam CT scanning for tbe diagncuis of 
characteristica compared with nonsmokers. The multivariable logistic coronary disease and the paucity of prognostic information avail- 
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regression helps us to define the correlation among these variables. 
Although ag.: clearly plays an important role, we agree that the better 
outcome is cmokers may well be related to the observed higher rate of 
Thmmboiysis in Myocardial Infarction grade 3 flow in this group as 
well as overall less extensive coronalr disease. The mechmism for the 
apparent better response to thrombolysis remains unclear and, as 
stated In the report, may derive from a different underlying pathogenic 
mechanism of the coronary lesions in these patients. 
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Prognostic Value of Coronary Calcification-l 
Inexplicably, Detrano et al. (1) have excluded coronary revasmdarii- 
tion procedures from their analysis of coronary events in 491 symp 
tomatic adults undergoing coronary arteriography for clinical indica- 
tions. This omission is serious, for it assumes that coronary 
tevascularization procedures fail to prevent nonfatal myocardial in- 
farction or comnaty death. The decision to exclude comnaty revascu- 
larixation procedures also raixs a series of questions: 
1. How were procedure-related deaths and myocardial infarctions 
analyxed? 
2. Did any patients undergo either coronary angioplasty or bypass 
surgery between the time of coronary arteriography and electron 
beam computed tomographic (CT) scanning? 
3. Was this a study of patients undergoing elective cardiac catheter- 
ization, or were patients admitted to the hospital for unstable 
angina, acute myocardial infarction or congestive heart failure also 
included in the study? 
4. How do angiography and electron beam Cf compare when rcvas- 
cularixation procedures are included? 
A statement in the methods section (“scan results did not gene- 
influence the decision to perform coronary angiogmphy”) raises two 
other questions related to the appropriateness of the deck&n to 
exclude coronary revascularixation proccdurcs from the analysis: 
